Search for: "Apotex, Inc. " Results 1 - 20 of 675
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Apr 2015, 9:59 pm by Patent Docs
Of course, the Federal Circuit explained this week in the Apotex Inc. v. [read post]
9 Nov 2011, 9:59 pm by Patent Docs
("Apotex"); and affirmed the District Court's holding that Apotex Inc. is jointly and severally liable for all damages. [read post]
14 Apr 2014, 9:59 pm by Patent Docs
Apotex Inc. that is a cautionary tale of patent lifecycle and the difficulties those seeking to extend patent protection face -- namely the blooming of prior art relating to an approved product. [read post]
31 Mar 2011, 2:46 am by traceydennis
Les Laboratoires Servier and another v Apotex Inc and others [2010] EWHC 730 (Pat); [2011] WLR (D) 111 “The court would not award compensation under a cross-undertaking for the loss sustained by an unlawful business or where the beneficiary of the cross-undertaking had to rely to a substantial extent upon his own illegality in order to establish the loss, provided the unlawfulness was sufficiently serious to engage the ex turpi causa rule. [read post]
9 May 2012, 1:52 am by sally
Les Laboratoires Servier and another v Apotex Inc and others [2012] EWCA Civ 593; [2012] WLR (D) 138 “The court was able to take into account a wide range of considerations in order to ensure that the ex turpi causa defence only applied where it was a just and proportionate response to the illegality in question. [read post]
12 Aug 2012, 9:07 pm by Patent Docs
Apotex Inc. last Wednesday, Judge Moore took issue with a position advanced by Alcon's counsel that would have essentially allowed a court to rewrite patent claims to preserve validity. [read post]
10 Jun 2014, 5:25 pm by Lawrence B. Ebert
ApotexApotex Inc., Apotex Corp., Sandoz, Inc., Hit-TechPharmacal Co., Inc., Actavis, Inc., Watson Laboratories,Inc., and Watson Pharma, Inc. [read post]
26 Feb 2015, 9:43 am by Morse, Barnes-Brown Pendleton
Brougher On February 18, 2015, Apotex Inc., announced that the Food and Drug Administration (FDA) had accepted its application for a biosimilar version of Amgen Inc’s Neupogen®. [read post]
7 Apr 2014, 9:59 pm by Patent Docs
The case involved patentee Senju Pharmaceutical's (joined by Kyorin Pharmaceutical Co. and Allergan, Inc.) suit against Apotex in response to a Paragraph IV certification against Senju's patented ocular antimicrobial agent containing the drug Gatifloxacin as claimed in U.S. [read post]
23 Apr 2012, 1:46 pm
Lilly alleges that Apotex seeks approval for ANDA and that the product infringes its patents. [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
10 Jul 2008, 4:50 am
Patent No. 5,110,493, which is owned by Plaintiff-Appellee Roche Palo Alto LLC, is valid and infringed by Defendants-Appellants Apotex, Inc. and Apotex Corp. [read post]
2 Sep 2014, 9:41 pm by Patent Docs
Allergan had asserted its 7,351,404 patent (the '404 patent) and Duke asserted its 7,388,029 patent (the '029 patent) after Apotex filed an ANDA for a generic version of Allergan's Latisse®, an ophthalmic solution comprising bimatoprost (a prostaglandin F-2-alpha ("PGF") analog) as the active ingredient. [read post]
19 Aug 2014, 9:59 pm by Patent Docs
Noonan -- Last week, the Federal Circuit affirmed a finding of inequitable conduct in Apotex v. [read post]